Abstract
Mutations that arise in mitochondrial DNA (mtDNA) may be sporadic, maternally inherited, or Mendelian in character and include mtDNA rearrangements such as deletions, inversions or duplications, point mutations, or copy number depletion. Primary mtDNA mutations occur sporadically or exhibit maternal inheritance and arise due in large part to the high mutation rate of mtDNA. mtDNA mutations may also occur because of defects in the biogenesis or maintenance of mtDNA, reflecting the contribution of nuclear-encoded genes to these processes, and in this case exhibit Mendelian inheritance. Whether maternally inherited, sporadic, or Mendelian, mtDNA mutations can exhibit a complex and broad spectrum of disease manifestations due to the central role mitochondria play in a variety of cellular functions. In addition, because there exist hundreds to thousands of copies of mtDNA in each cell, the proportion of mutant mtDNA molecules can have a profound effect on the cellular and clinical phenotype. This chapter reviews the classification of mtDNA mutations and the clinical features that determine the diagnosis of a primary mtDNA disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liu, Z., and Butow, R. A. (2006) Mitochondrial retrograde signaling, Annu Rev Genet 40, 159–185.
Brookes, P. S., Yoon, Y., Robotham, J. L., et al. (2004) Calcium, ATP, and ROS: a mitochondrial love-hate triangle, Am J Physiol Cell Physiol 287, C817–833.
Acin-Perez, R., Salazar, E., Kamenetsky, M., et al. (2009) Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation, Cell Metab 9, 265–276.
Acin-Perez, R., Hoyos, B., Gong, J., et al. (2010) Regulation of intermediary metabolism by the PKCdelta signalosome in mitochondria, FASEB J 24, 5033–5042.
Yao, Z., and Seger, R. (2009) The ERK signaling cascade--views from different subcellular compartments, Biofactors 35, 407–416.
Shaw, P. E. (2010) Could STAT3 provide a link between respiration and cell cycle progression?, Cell Cycle 9, 4294–4296.
Mookherjee, P., Quintanilla, R., Roh, M. S., et al. (2007) Mitochondrial-targeted active Akt protects SH-SY5Y neuroblastoma cells from staurosporine-induced apoptotic cell death, J Cell Biochem 102, 196–210.
Reeve, A. K., Krishnan, K. J., and Turnbull, D. (2008) Mitochondrial DNA mutations in disease, aging, and neurodegeneration, Ann N Y Acad Sci 1147, 21–29.
Smits, P., Smeitink, J., and van den Heuvel, L. (2010) Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies, J Biomed Biotechnol 2010, 737385.
Zeviani, M., and Di Donato, S. (2004) Mitochondrial disorders, Brain 127, 2153–2172.
Schatz, G. (1963) The Isolation of Possible Mitochondrial Precursor Structures from Aerobically Grown Baker’s Yeast, Biochem Biophys Res Commun 12, 448–451.
Nass, M. M., and Nass, S. (1963) Intramitochondrial Fibers with DNA Characteristics. I. Fixation and Electron Staining Reactions, J Cell Biol 19, 593–611.
Holt, I. J., Harding, A. E., and Morgan-Hughes, J. A. (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies, Nature 331, 717–719.
Zeviani, M., Moraes, C. T., DiMauro, S., et al. (1988) Deletions of mitochondrial DNA in Kearns-Sayre syndrome, Neurology 38, 1339–1346.
Lestienne, P., and Ponsot, G. (1988) Kearns-Sayre syndrome with muscle mitochondrial DNA deletion, Lancet 1, 885.
Wallace, D. C., Singh, G., Lott, M. T., et al. (1988) Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy, Science 242, 1427–1430.
Shoffner, J. M., Lott, M. T., Lezza, A. M., et al. (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation, Cell 61, 931–937.
Goto, Y., Nonaka, I., and Horai, S. (1990) A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies, Nature 348, 651–653.
Prezant, T. R., Agapian, J. V., Bohlman, M. C., et al. (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness, Nat Genet 4, 289–294.
Brown, W. M., Prager, E. M., Wang, A., et al. (1982) Mitochondrial DNA sequences of primates: tempo and mode of evolution, J Mol Evol 18, 225–239.
Parson, W., and Bandelt, H. J. (2007) Extended guidelines for mtDNA typing of population data in forensic science, Forensic Sci Int Genet 1, 13–19.
Ghelli, A., Porcelli, A. M., Zanna, C., et al. (2009) The background of mitochondrial DNA haplogroup J increases the sensitivity of Leber’s hereditary optic neuropathy cells to 2,5-hexanedione toxicity, PLoS One 4, e7922.
Gomez-Duran, A., Pacheu-Grau, D., Lopez-Gallardo, E., et al. (2010) Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups, Hum Mol Genet 19, 3343–3353.
Thorburn, D. R. (2004) Mitochondrial disorders: prevalence, myths and advances, J Inherit Metab Dis 27, 349–362.
Skladal, D., Halliday, J., and Thorburn, D. R. (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children, Brain 126, 1905–1912.
Diogo, L., Grazina, M., Garcia, P., et al. (2009) Pediatric mitochondrial respiratory chain disorders in the Centro region of Portugal, Pediatr Neurol 40, 351–356.
Chinnery, P. F., Johnson, M. A., Wardell, T. M., et al. (2000) The epidemiology of pathogenic mitochondrial DNA mutations, Ann Neurol 48, 188–193.
Schaefer, A. M., McFarland, R., Blakely, E. L., et al. (2008) Prevalence of mitochondrial DNA disease in adults, Ann Neurol 63, 35–39.
Elliott, H. R., Samuels, D. C., Eden, J. A., et al. (2008) Pathogenic mitochondrial DNA mutations are common in the general population, Am J Hum Genet 83, 254–260.
Schwartz, M., and Vissing, J. (2002) Paternal inheritance of mitochondrial DNA, N Engl J Med 347, 576–580.
Kraytsberg, Y., Schwartz, M., Brown, T. A., et al. (2004) Recombination of human mitochondrial DNA, Science 304, 981.
Cree, L. M., Samuels, D. C., de Sousa Lopes, S. C., et al. (2008) A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes, Nat Genet 40, 249–254.
Wai, T., Teoli, D., and Shoubridge, E. A. (2008) The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes, Nat Genet 40, 1484–1488.
Cao, L., Shitara, H., Sugimoto, M., et al. (2009) New evidence confirms that the mitochondrial bottleneck is generated without reduction of mitochondrial DNA content in early primordial germ cells of mice, PLoS Genet 5, e1000756.
Battersby, B. J., Loredo-Osti, J. C., and Shoubridge, E. A. (2003) Nuclear genetic control of mitochondrial DNA segregation, Nat Genet 33, 183–186.
Jenuth, J. P., Peterson, A. C., and Shoubridge, E. A. (1997) Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice, Nat Genet 16, 93–95.
Jokinen, R., Marttinen, P., Sandell, H. K., et al. (2010) Gimap3 regulates tissue-specific mitochondrial DNA segregation, PLoS Genet 6, e1001161.
Pearson, H. A., Lobel, J. S., Kocoshis, S. A., et al. (1979) A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction, J Pediatr 95, 976–984.
Hammans, S. R. (1994) Mitochondrial DNA and disease, Essays Biochem 28, 99–112.
Schroder, R., Vielhaber, S., Wiedemann, F. R., et al. (2000) New insights into the metabolic consequences of large-scale mtDNA deletions: a quantitative analysis of biochemical, morphological, and genetic findings in human skeletal muscle, J Neuropathol Exp Neurol 59, 353–360.
Wong, L. J. (2001) Recognition of mitochondrial DNA deletion syndrome with non-neuromuscular multisystemic manifestation, Genet Med 3, 399–404.
Samuels, D. C., Schon, E. A., and Chinnery, P. F. (2004) Two direct repeats cause most human mtDNA deletions, Trends Genet 20, 393–398.
Degoul, F., Nelson, I., Amselem, S., et al. (1991) Different mechanisms inferred from sequences of human mitochondrial DNA deletions in ocular myopathies, Nucleic Acids Res 19, 493–496.
Holt, I. J., Lorimer, H. E., and Jacobs, H. T. (2000) Coupled leading- and lagging-strand synthesis of mammalian mitochondrial DNA, Cell 100, 515–524.
Krishnan, K. J., Reeve, A. K., Samuels, D. C., et al. (2008) What causes mitochondrial DNA deletions in human cells?, Nat Genet 40, 275–279.
Sadikovic, B., Wang, J., El-Hattab, A., et al. (2010) Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes, PLoS One 5, e15687.
Helm, M. (2006) Post-transcriptional nucleotide modification and alternative folding of RNA, Nucleic Acids Res 34, 721–733.
Florentz, C., Sohm, B., Tryoen-Toth, P., et al. (2003) Human mitochondrial tRNAs in health and disease, Cell Mol Life Sci 60, 1356–1375.
Finsterer, J. (2007) Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation, Acta Neurol Scand 116, 1–14.
Koga, Y., Akita, Y., Nishioka, J., et al. (2005) L-arginine improves the symptoms of strokelike episodes in MELAS, Neurology 64, 710–712.
Kirino, Y., Yasukawa, T., Ohta, S., et al. (2004) Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease, Proc Natl Acad Sci USA 101, 15070–15075.
Hess, J. F., Parisi, M. A., Bennett, J. L., et al. (1991) Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies, Nature 351, 236–239.
Shanske, S., Coku, J., Lu, J., et al. (2008) The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases, Arch Neurol 65, 368–372.
Chomyn, A., Martinuzzi, A., Yoneda, M., et al. (1992) MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts, Proc Natl Acad Sci USA 89, 4221–4225.
Enriquez, J. A., Chomyn, A., and Attardi, G. (1995) MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination, Nat Genet 10, 47–55.
Holt, I. J., Harding, A. E., Petty, R. K., et al. (1990) A new mitochondrial disease associated with mitochondrial DNA heteroplasmy, Am J Hum Genet 46, 428–433.
Makela-Bengs, P., Suomalainen, A., Majander, A., et al. (1995) Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome, Pediatr Res 37, 634–639.
Shankar, S. P., Fingert, J. H., Carelli, V., et al. (2008) Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy, Ophthalmic Genet 29, 17–24.
Tonska, K., Kodron, A., and Bartnik, E. (2010) Genotype-phenotype correlations in Leber hereditary optic neuropathy, Biochim Biophys Acta 1797, 1119–1123.
Torroni, A., Petrozzi, M., D’Urbano, L., et al. (1997) Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484, Am J Hum Genet 60, 1107–1121.
O’Brien, T. W. (2003) Properties of human mitochondrial ribosomes, IUBMB Life 55, 505–513.
Lu, J., Qian, Y., Li, Z., et al. (2010) Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12 S rRNA 1555A  >  G mutation, Mitochondrion 10, 69–81.
Bykhovskaya, Y., Mengesha, E., Wang, D., et al. (2004) Human mitochondrial transcription factor B1 as a modifier gene for hearing loss associated with the mitochondrial A1555G mutation, Mol Genet Metab 82, 27–32.
Guan, M. X., Yan, Q., Li, X., et al. (2006) Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12 S ribosomal RNA mutations, Am J Hum Genet 79, 291–302.
Zeharia, A., Shaag, A., Pappo, O., et al. (2009) Acute infantile liver failure due to mutations in the TRMU gene, Am J Hum Genet 85, 401–407.
Acknowledgment
Thanks to Sha Tang, PhD, for creating Fig. 1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Craigen, W.J. (2012). Mitochondrial DNA Mutations: An Overview of Clinical and Molecular Aspects. In: Wong, Ph.D., LJ. (eds) Mitochondrial Disorders. Methods in Molecular Biology, vol 837. Humana Press. https://doi.org/10.1007/978-1-61779-504-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-61779-504-6_1
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-503-9
Online ISBN: 978-1-61779-504-6
eBook Packages: Springer Protocols